Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent

Combination therapy for visceral leishmaniasis

(2010) Johan van Griensven et al.   LANCET INFECTIOUS DISEASES

Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India

(2010) Shyam Sundar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal - the challenges for diagnosis and treatment

(2010) Shyam Sundar et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Short‐Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14‐Day vs 21‐Day Treatment

(2009) Shyam Sundar et al.   CLINICAL INFECTIOUS DISEASES

Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India

(2009) Piero Olliaro et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India

(2009) M. Boelaert et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

New Treatment Approach in Indian Visceral Leishmaniasis: Single‐Dose Liposomal Amphotericin B Followed by Short‐Course Oral Miltefosine

(2008) Shyam Sundar et al.   CLINICAL INFECTIOUS DISEASES

Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India

(2008) P. Olliaro et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH